Monitoring misinformation, building discernment: A crowdsourcing study during the 2025 Australian federal election
Harvard Kennedy School Misinformation Review · 2026
DOI: 10.37016/mr-2020-210 ↗Kurz gefasst
Fachartikel in der Zeitschrift Harvard Kennedy School Misinformation Review, 2026. Verfasst von Ariel Kruger und 2 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben.
Abstract (Originalsprache)
We conducted a design evaluation exploring whether a structured crowdsourcing system using trained volunteers could monitor and categorize election-related misinformation during the 2025 Australian federal election campaign. Over six weeks, 90 active participants surfaced 592 potentially misinforming posts and provided over 3,000 assessments across multiple platforms and recurring narratives. Participants classified content with meaningful accuracy against an independent assessor, with inter-rater agreement varying by category. A follow-up three months later found that participants showed higher misinformation discernment than a separately recruited control group. Structured crowdsourcing may, therefore, serve as a scalable monitoring mechanism and, more tentatively, a potential pathway to building resilience to misinformation.
Zitieren
APA
Kruger, A., Howe, P., & Saletta, M. (2026). Monitoring misinformation, building discernment: A crowdsourcing study during the 2025 Australian federal election. Harvard Kennedy School Misinformation Review. https://doi.org/10.37016/mr-2020-210
Vancouver
Kruger A, Howe P, Saletta M. Monitoring misinformation, building discernment: A crowdsourcing study during the 2025 Australian federal election. Harvard Kennedy School Misinformation Review. 2026. doi:10.37016/mr-2020-210
BibTeX
@article{Kruger2026,
author = {Kruger, Ariel and Howe, Piers and Saletta, Morgan},
title = {Monitoring misinformation, building discernment: A crowdsourcing study during the 2025 Australian federal election},
journal = {Harvard Kennedy School Misinformation Review},
year = {2026},
doi = {10.37016/mr-2020-210}
}
EUVIMED